Your session is about to expire
← Back to Search
Beef
Burger Types for Inflammation
N/A
Waitlist Available
Led By Stephan van Vliet, PhD
Research Sponsored by Utah State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately before meal
Awards & highlights
No Placebo-Only Group
Summary
This trial studies how different types of meat (regular beef, grass-fed beef, plant-based burger) affect inflammation and health markers in overweight or obese middle-aged adults. Blood samples are taken to measure these effects.
Who is the study for?
This trial is for overweight or obese adults aged 30-60 who have been weight stable in the past 3 months. Participants must not be heavy drinkers, pregnant, lactating, allergic to soy, smokers, or have certain health conditions like diabetes or heart failure. They should not be on medications affecting inflammation and can't have had a recent COVID vaccine.
What is being tested?
The study compares the effects of consuming a grain-fed beef hamburger, grass-fed beef hamburger, or an Impossible Burger on blood markers of inflammation and metabolism. Each participant will eat each type of burger on separate visits with blood samples taken before and after meals at specific intervals.
What are the potential side effects?
There are no direct side effects from eating the burgers mentioned in the study; however, participants may experience discomfort from frequent blood draws such as bruising at the needle site.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from fasting concentrations after eating.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from fasting concentrations after eating.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Inflammatory cytokine biomarker (C-reactive protein) concentrations in plasma samples
Inflammatory cytokine biomarker (IL-6) concentrations in plasma samples
Inflammatory cytokine biomarker (TNF-alpha) concentrations in plasma samples
+2 moreSecondary study objectives
Mood Questionnaires
Satiety Questionnaire
Taste Questionnaire
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
6Treatment groups
Active Control
Group I: Sequence 6: Grass-Fed, Impossible, Grain-FedActive Control3 Interventions
On the first visit, a grass-fed beef burger (250 grams) will be consumed.
On the second visit, an Impossible BurgerTM (250 grams) will be consumed.
On the third visit, a grain-fed beef burger (250 grams) will be consumed.
Group II: Sequence 5: Grain-Fed, Impossible, Grass-FedActive Control3 Interventions
On the first visit, a grain-fed beef burger (250 grams) will be consumed.
On the second visit, an Impossible BurgerTM (250 grams) will be consumed.
On the third visit, a grass-fed beef burger (250 grams) will be consumed.
Group III: Sequence 3: Impossible, Grass-Fed, Grain-FedActive Control3 Interventions
On the first visit, an Impossible BurgerTM (250 grams) will be consumed.
On the second visit, a grass-fed beef burger (250 grams) will be consumed.
On the third visit, a grain-fed beef burger (250 grams) will be consumed.
Group IV: Sequence 4: Impossible, Grain-Fed, Grass-FedActive Control3 Interventions
On the first visit, an Impossible BurgerTM (250 grams) will be consumed.
On the second visit, a grain-fed beef burger (250 grams) will be consumed.
On the third visit, a grass-fed beef burger (250 grams) will be consumed.
Group V: Sequence 1: Grain-Fed, Grass-Fed, ImpossibleActive Control3 Interventions
On the first visit, a grain-fed beef burger (250 grams) will be consumed.
On the second visit, a grass-fed beef burger (250 grams) will be consumed.
On the third visit, an Impossible BurgerTM (250 grams) will be consumed.
Group VI: Sequence 2: Grass-Fed, Grain-Fed, ImpossibleActive Control3 Interventions
On the first visit, a grass-fed beef burger (250 grams) will be consumed.
On the second visit, a grain-fed beef burger (250 grams) will be consumed.
On the third visit, an Impossible BurgerTM (250 grams) will be consumed.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for inflammation often target the reduction of inflammatory markers and the modulation of metabolite profiles in the blood. Dietary interventions, such as the consumption of different types of meat (grain-fed beef, grass-fed beef) and plant-based alternatives (Impossible Burger), can influence these markers.
For instance, grass-fed beef may have a different fatty acid profile compared to grain-fed beef, potentially leading to lower levels of pro-inflammatory markers. Plant-based alternatives might offer benefits through higher levels of phenolics and other anti-inflammatory compounds.
These dietary choices matter for inflammation patients as they can modulate the body's inflammatory response, potentially reducing chronic inflammation and associated risks of diseases such as cardiovascular conditions and metabolic disorders.
Find a Location
Who is running the clinical trial?
Duke UniversityOTHER
2,458 Previous Clinical Trials
2,969,413 Total Patients Enrolled
12 Trials studying Inflammation
3,517 Patients Enrolled for Inflammation
United States Department of Agriculture (USDA)FED
100 Previous Clinical Trials
286,643 Total Patients Enrolled
6 Trials studying Inflammation
314 Patients Enrolled for Inflammation
Utah State UniversityLead Sponsor
45 Previous Clinical Trials
4,722 Total Patients Enrolled
5 Trials studying Inflammation
156 Patients Enrolled for Inflammation
Stephan van Vliet, PhDPrincipal InvestigatorUtah State University
1 Previous Clinical Trials
21 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not on medications that could interfere with the study.I have a history of inflammatory diseases like arthritis or hepatitis.I am between 30 and 60 years old.I am unable to understand and give voluntary consent for treatment.I received a COVID vaccine in the last two weeks.I have been diagnosed with cancer, heart failure, diabetes, or COPD.The study leader thinks I can't safely follow the study plan.I have not taken antibiotics in the last 60 days.
Research Study Groups:
This trial has the following groups:- Group 1: Sequence 6: Grass-Fed, Impossible, Grain-Fed
- Group 2: Sequence 5: Grain-Fed, Impossible, Grass-Fed
- Group 3: Sequence 3: Impossible, Grass-Fed, Grain-Fed
- Group 4: Sequence 4: Impossible, Grain-Fed, Grass-Fed
- Group 5: Sequence 1: Grain-Fed, Grass-Fed, Impossible
- Group 6: Sequence 2: Grass-Fed, Grain-Fed, Impossible
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.